Immunoassay

Patent No. EP2936152 (titled "Immunoassay") was filed by Lumiradx UK on Dec 23, 2013. The application was issued on Apr 22, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA	Jan 22, 2021	RICHTER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 27, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Sep 27, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Sep 22, 2021
Termination of the opposition proceedings with revocation of patent
Jul 19, 2021
(Electronic) Receipt
Jul 19, 2021
Advice of delivery
Jul 19, 2021
Letter accompanying subsequently filed items
Jul 16, 2021
Communication about missing advice of delivery
Jun 16, 2021
Advice of delivery
Jun 10, 2021
Decision revoking the European patent
Jun 10, 2021
Decision revoking the European patent
Jun 10, 2021
Transmittal of decision / summons - opposition
Jun 10, 2021
Transmittal of decision / summons - opposition
Jun 4, 2021
(Electronic) Receipt
Jun 4, 2021
Letter accompanying subsequently filed items
Jun 4, 2021
Request for revocation of patent
Feb 8, 2021
Communication of a notice of opposition and request to file observations
Feb 8, 2021
Notice of further oppositions to opponent(s)
Feb 2, 2021
Communication of a notice of opposition - first information to patent proprietor
Jan 28, 2021
International publication (Pamphlet)
Jan 22, 2021
(Electronic) Receipt
Jan 22, 2021
Citation in opposition procedure - 001
Jan 22, 2021
Citation in opposition procedure - 002
Jan 22, 2021
Citation in opposition procedure - 003
Jan 22, 2021
Citation in opposition procedure - 004
Jan 22, 2021
Citation in opposition procedure - 005
Jan 22, 2021
Citation in opposition procedure - 006
Jan 22, 2021
Citation in opposition procedure - 007
Jan 22, 2021
Citation in opposition procedure - 008
Jan 22, 2021
Citation in opposition procedure - 009
Jan 22, 2021
Citation in opposition procedure - 010
Jan 22, 2021
Citation in opposition procedure - 011
Jan 22, 2021
Citation in opposition procedure - 012
Jan 22, 2021
Consolidated list of cited opposition documents
Jan 22, 2021
Letter accompanying subsequently filed items
Jan 22, 2021
Notice of opposition
Jan 22, 2021
Notice of opposition
Mar 12, 2020
(Electronic) Receipt
Mar 12, 2020
Filing of the translations of the claims
Mar 12, 2020
French translation of claims
Mar 12, 2020
German translation of the claims
Nov 22, 2019
Bibliographic data of the European patent application
Nov 22, 2019
Communication about intention to grant a European patent
Nov 22, 2019
Intention to grant (signatures)
Nov 22, 2019
Text intended for grant (clean copy)
Nov 22, 2019
Text intended for grant (version for approval)
Nov 11, 2019
Result of consultation by telephone/in person
Nov 5, 2019
(Electronic) Receipt
Nov 5, 2019
Annexes in respect of a client data request
Nov 5, 2019
Letter accompanying subsequently filed items
Nov 5, 2019
Submission concerning a transfer of rights (applicant)
Jun 24, 2019
Communication from the Legal Division
Jun 4, 2019
(Electronic) Receipt
Jun 4, 2019
Annex
Jun 4, 2019
Annex
Jun 4, 2019
Annex
Jun 4, 2019
Annex
Jun 4, 2019
Letter accompanying subsequently filed items
Jun 4, 2019
Letter to the Legal Division
Apr 25, 2019
Communication from the Legal Division
Apr 5, 2019
(Electronic) Receipt
Apr 5, 2019
Annex
Apr 5, 2019
Letter accompanying subsequently filed items
Apr 5, 2019
Letter to the Legal Division
Aug 16, 2018
(Electronic) Receipt
Aug 16, 2018
Amended claims with annotations
Aug 16, 2018
Claims
Aug 16, 2018
Letter accompanying subsequently filed items
Aug 16, 2018
Request for further processing
Jun 20, 2018
Application deemed to be withdrawn (no reply to communication from the Examining Division)
Mar 15, 2018
Grant of extension of time limit (examination procedure)
Mar 12, 2018
(Electronic) Receipt
Mar 12, 2018
Letter accompanying subsequently filed items
Mar 12, 2018
Request for extension of time limit to communication from the Examining Division
Feb 2, 2018
Notice drawing attention to the payment of the renewal fee and additional fee
Nov 14, 2017
Annex to the communication
Nov 14, 2017
Consultation by telephone/in person (with time limit)
Nov 14, 2017
Result of consultation by telephone/in person
Jun 13, 2017
Decision to allow further processing
May 31, 2017
(Electronic) Receipt
May 31, 2017
Amended claims with annotations
May 31, 2017
Claims
May 31, 2017
Letter accompanying subsequently filed items
May 31, 2017
Request for further processing
Mar 27, 2017
Application deemed to be withdrawn (no reply to communication from the Examining Division)
Feb 3, 2017
Notice drawing attention to the payment of the renewal fee and additional fee
Dec 22, 2016
Grant of extension of time limit (examination procedure)
Dec 19, 2016
(Electronic) Receipt
Dec 19, 2016
Letter accompanying subsequently filed items
Dec 19, 2016
Request for extension of time limit to communication from the Examining Division
Aug 19, 2016
Annex to the communication
Aug 19, 2016
Communication from the Examining Division
Aug 11, 2016
Examination started
Feb 3, 2016
Notice drawing attention to the payment of the renewal fee and additional fee
Feb 1, 2016
(Electronic) Receipt
Feb 1, 2016
Amended claims filed after receipt of (European) search report
Feb 1, 2016
Amended claims with annotations
Feb 1, 2016
Amendments received before examination
Feb 1, 2016
Letter accompanying subsequently filed items
Sep 30, 2015
Notification on forthcoming publication of bibliographic data
Jul 31, 2015
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Jul 29, 2015
Communication to designated inventor
Jul 29, 2015
Communication to designated inventor
Jul 29, 2015
Communication to designated inventor
Jul 29, 2015
Communication to designated inventor
Jul 21, 2015
(Electronic) Receipt
Jul 21, 2015
Request for entry into the European phase
Jul 7, 2015
Copy of the international preliminary report on patentability
May 4, 2015
Information on entry into European phase
Apr 14, 2015
Notification of the recording of a change
Jul 17, 2014
Priority document (electronically transmitted)
Jun 26, 2014
Copy of the international search report
Jun 26, 2014
Published international application - A1
Jan 29, 2014
Written opinion of the ISA, boxes No. I to VIII
Jan 29, 2014
Written opinion of the ISA, cover sheet
Jan 29, 2014
Written opinion of the ISA, supplemental box
Jan 3, 2014
Abstract
Jan 3, 2014
Claims
Jan 3, 2014
Description
Jan 3, 2014
Drawings

EP2936152

LUMIRADX UK

Application Number: EP13812049A
Filing Date: Dec 23, 2013
Status: Revoked; Sep 24, 2021
Publication Date: Apr 22, 2020
External Links: Slate, Register , Google Patents

IP Verse

Immunoassay

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2936152